US5658491064 - Common Stock
23.19 -0.07 (-0.3%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-05-19 | Mizuho | Maintains | Neutral -> Neutral |
2023-05-15 | Jefferies | Maintains | Hold -> Hold |
2023-05-08 | Wells Fargo | Maintains | Overweight |
2023-04-21 | Susquehanna | Maintains | Positive |
2023-04-21 | Raymond James | Maintains | Strong Buy |
2023-04-21 | Goldman Sachs | Maintains | Sell |
2023-04-19 | Piper Sandler | Maintains | Overweight |
2023-04-18 | Benchmark | Reiterate | Buy |
2023-04-18 | Wells Fargo | Maintains | Overweight |
2023-03-30 | Stifel | Maintains | Buy |
2023-03-27 | Raymond James | Maintains | Strong Buy |
2023-03-27 | Morgan Stanley | Maintains | Overweight |
2023-03-24 | Goldman Sachs | Maintains | Sell |
2023-03-23 | Citigroup | Upgrade | Neutral -> Buy |
2023-02-23 | Citigroup | Maintains | Neutral |
2023-02-21 | Wells Fargo | Maintains | Overweight |
2023-02-16 | Benchmark | Upgrade | Hold -> Buy |
2023-01-25 | Wells Fargo | Initiate | Overweight |
2023-01-24 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
2023-01-13 | Piper Sandler | Maintains | Overweight |
2023-01-13 | Citigroup | Maintains | Neutral |
2023-01-10 | Mizuho | Downgrade | Buy -> Neutral |
2022-12-07 | Barclays | Maintains | Overweight |
2022-11-28 | Raymond James | Maintains | Strong Buy |
2022-11-23 | Goldman Sachs | Maintains | Sell |
2022-11-17 | Piper Sandler | Maintains | Overweight |
2022-11-07 | RBC Capital | Maintains | Outperform |
2022-11-03 | Credit Suisse | Maintains | Neutral |
2022-10-24 | Raymond James | Maintains | Strong Buy |
2022-10-19 | Barclays | Maintains | Overweight |
Find the competitors with the best analyst ratings on the USA